Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Cabozantinib in Combination With Atezolizumab for Advanced Renal Cell Carcinoma: Results From the COSMIC-021 Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology Pal, S. K., McGregor, B., Suarez, C., Tsao, C., Kelly, W., Vaishampayan, U., Pagliaro, L., Maughan, B. L., Loriot, Y., Castellano, D., Srinivas, S., McKay, R. R., Dreicer, R., Hutson, T., Dubey, S., Werneke, S., Panneerselvam, A., Curran, D., Scheffold, C., Choueiri, T. K., Agarwal, N. 2021: JCO2100939
[Figure: see text].
View details for DOI 10.1200/JCO.21.00939
View details for PubMedID 34491815